Test to determine if there is a mutation in the FLT3 tyrosine kinase domain of the FLT3 gene in AML patients.
NOTE: FLT3 tyrosine kinase domain variants will also be detected on the Myeloid NGS Panel at a sensitivity of 5%. Please refer to the Myeloid NGS Panel in Test Manager for more details and price.
Genetics - Molecular Oncology
2x EDTA (Lavender) dedicated to Genetics (same sample can be used for FLT3/NPM1/CEBPA)
Send to MONC
8 ml peripheral blood in EDTA. 1-3 ml of bone marrow in EDTA or RPMI (anticoagulant).
Send ambient to the laboratory.
PCR of the tyrosine kinase domain region of the FLT3 gene followed by EcoRV restriction enzyme digest.
$351.22 (Exclusive of GST)
"*" indicates required fields